4月30日，康辰药业获西南证券买入评级，近一个月康辰药业获得5份研报关注。
研报预计2024-2026年归母净利润分别为1.9亿元、2.3亿元和2.9亿元。研报认为，随着公司苏灵等存量产品快速增长，多措并举完善创新体系布局，KC1036已展现优异临床疗效。
风险提示：市场竞争风险、药品价格下行风险、新药研发风险。
English
Back
- Markets
- Features
- News
- Community
- Learn
- Help Center
- About
- Offers & Rewards
- Welcome RewardsOpen an account and get up to HKD1800!
- Enjoy limited-time 5%+5% returns on Cash PlusInvest any amount and enjoy a 5% average return on Cash Plus + 5% welcome reward
- Join Futubull Membership ProgramUnlock 11 Premier Benefits
- Referral PromotionBring a friend and collect up to HK$600 in rewards
- Learn PremiumAnalyst 1V1 online teaching
- Stock TransferSwitch to Futu and get up to HK$7,000 in rewards
- English
- 繁體中文
- 简体中文
- Dark
- Light
- Headlines
- 康辰药业获西南证券买入评级，苏灵销量快速增长，创新管线持续推进
康辰药业获西南证券买入评级，苏灵销量快速增长，创新管线持续推进
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Write a comment
0 0 0
LikeLoveLaughing CryRespectEmmSadAngry
Tap to Select a Mood
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
Use the share button in your browser
to share the page with your friends
Tap here to share
No comments yet. Write one.
Related Stocks Related Stocks
Symbol Mini Chart Latest Price
Unlock the Full List
Latest
15:18
The relevant person in charge of the Central Financial Office stated that it is necessary to stabilize the policy expectations and development confidence of private enterprises and effectively stimulate the vitality of private investment.
15:17
Huaxin Securities: Maintains "Buy" rating for Luzhou Laojiao, the pioneer of strong aroma liquor, deeply ingrained in people's hearts.
Luzhou Laojiao-3.77%
15:16
The person in charge of the Central Financial Office: Next year, efforts should be made to enhance consumer capacity and improve consumer willingness, while also working on adapting to changes in consumption structure and enhancing supply-demand compatibi
Statement
This page is machine-translated. Futubull tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation.